E. Cone

发表

Normalization of urinary drug concentrations with specific gravity and creatinine.

Tim Robert, Edward J Cone, Yale H Caplan, 2009, Journal of analytical toxicology.

Clinical pharmacology of buprenorphine: Ceiling effects at high doses

K. Preston, M. Stitzer, G. Bigelow, 1994, Clinical pharmacology and therapeutics.

Prescribing Opioids for Chronic Noncancer Pain in Primary Care: Risk Assessment

S. Passik, E. Cone, A. Gordon, 2014, Postgraduate medicine.

Risks and Responsibilities in Prescribing Opioids for Chronic Noncancer Pain, Part 2: Best Practices

S. Passik, E. Cone, A. Gordon, 2014, Postgraduate medicine.

Urine Toxicology Testing in Chronic Pain Management

E. Cone, Y. Caplan, 2009, Postgraduate medicine.

Ephemeral profiles of prescription drug and formulation tampering: evolving pseudoscience on the Internet.

E. Cone, 2006, Drug and alcohol dependence.

Pharmacokinetics: Drug Absorption, Distribution, and Elimination

E. Cone, A. Jenkins, 1997 .

Lack of cardiovascular tolerance during intravenous cocaine infusions in human volunteers.

J. Jaffe, E. Cone, K. Kumor, 1988, Life sciences.

Mechanisms of drug incorporation into hair.

E. Cone, E J Cone, 1996, Therapeutic drug monitoring.

Effects of the stereoisomers of nicotine and nornicotine on schedule-controlled responding and physiological parameters of dogs.

N. Benowitz, P. Jacob, E. Cone, 1988, The Journal of pharmacology and experimental therapeutics.

Estimation of available nicotine content of six smokeless tobacco products

J. Henningfield, E. Cone, A. Radzius, 1995 .

Behavioral economic demand metrics for abuse deterrent and abuse potential quantification.

Peter G. Roma, S. Hursh, S. Schnoll, 2019, Drug and alcohol dependence.

Oxycodone involvement in drug abuse deaths: a DAWN-based classification scheme applied to an oxycodone postmortem database containing over 1000 cases.

D. Spyker, J. Rohay, E. Cone, 2003, Journal of analytical toxicology.

Urine drug testing of chronic pain patients. III. Normetabolites as biomarkers of synthetic opioid use.

R. Heltsley, E. Cone, Y. Caplan, 2010, Journal of analytical toxicology.

63Ni electron-capture gas chromatographic assay for buprenorphine and metabolites in human urine and feces.

E. Cone, C. Gorodetzky, D. Yousefnejad, 1985, Journal of chromatography.

Relationship of plasma buprenorphine and norbuprenorphine to withdrawal symptoms during dose induction, maintenance and withdrawal from sublingual buprenorphine.

E. Cone, R. E. Johnson, P. Fudala, 1998, Addiction.

Detection times of marijuana metabolites in urine by immunoassay and GC-MS.

M. Huestis, E. Cone, J. Mitchell, 1995, Journal of analytical toxicology.

Testing human hair for drugs of abuse. II. Identification of unique cocaine metabolites in hair of drug abusers and evaluation of decontamination procedures.

E. Cone, E J Cone, D Yousefnejad, 1991, Journal of analytical toxicology.

Chapter 2 Current methods for the separation and analysis of cocaine analytes

E. Cone, R. J. Phipps, W. D. Darwin, 2008 .

Interpreting Alternative Matrix Test Results

M. Huestis, E. Cone, Angela Sampson-Cone, 2007 .

Simultaneous quantification of methamphetamine, cocaine, codeine, and metabolites in skin by positive chemical ionization gas chromatography-mass spectrometry.

M. Ripple, M. Huestis, E. Cone, 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Drug testing with alternative matrices I. Pharmacological effects and disposition of cocaine and codeine in plasma, sebum, and stratum corneum.

E. Cone, J. Oyler, R. Joseph, 1998, Journal of analytical toxicology.

In vitro characterization of cocaine binding sites in human hair.

L. Tsao, T. Su, E. Cone, 1997, The Journal of pharmacology and experimental therapeutics.

In vitro binding studies of drugs to hair: influence of melanin and lipids on cocaine binding to Caucasoid and Africoid hair.

T. Su, E. Cone, R. Joseph, 1996, Journal of analytical toxicology.

Quantitative analysis of THC, 11-OH-THC, and THCCOOH in human hair by negative ion chemical ionization mass spectrometry.

H. Haughey, M. Huestis, E. Cone, 1995, Journal of analytical toxicology.

Interference by nonsteroidal anti-inflammatory drugs in EMIT and TDx assays for drugs of abuse.

E. Cone, D. Smith, R. Joseph, 1995, Journal of analytical toxicology.

Testing human hair for drugs of abuse. IV. Environmental cocaine contamination and washing effects.

E. Cone, W. L. Wang, 1995, Forensic science international.

Simultaneous assay of cocaine, heroin and metabolites in hair, plasma, saliva and urine by gas chromatography-mass spectrometry.

E. Cone, W. D. Darwin, W. L. Wang, 1994, Journal of chromatography. B, Biomedical applications.

Cerebral Responses to Single and Multiple Cocaine Injections in Newborn Sheep

R. Traystman, E. London, E. Cone, 1994, Pediatric Research.

The occurrence of cocaine, heroin and metabolites in hair of drug abusers.

E. Cone, W. D. Darwin, W. L. Wang, 1993, Forensic science international.

Rapid assay of cocaine, opiates and metabolites by gas chromatography-mass spectrometry.

E. Cone, W. D. Darwin, W. Darwin, 1992, Journal of chromatography.

Urinary elimination of cocaine metabolites in chronic cocaine users during cessation.

D. Epstein, K. Preston, M. Huestis, 2002, Journal of analytical toxicology.

Elimination of cocaine and metabolites in plasma, saliva, and urine following repeated oral administration to human volunteers.

E. Cone, S. Walsh, B. Levine, 2000, Journal of analytical toxicology.

Cocaine and metabolite elimination patterns in chronic cocaine users during cessation: plasma and saliva analysis.

K. Preston, M. Huestis, E. Cone, 2000, Journal of analytical toxicology.

Occurrence of cocaine in urine of substance-abuse treatment patients.

K. Preston, E. Cone, B. Goldberger, 1998, Journal of analytical toxicology.

Assessment of cocaine use with quantitative urinalysis and estimation of new uses.

K. Preston, K. Silverman, E. Cone, 1997, Addiction.

Use of quantitative urinalysis in monitoring cocaine use.

K. Preston, K. Silverman, E. Cone, 1997, NIDA research monograph.

Nicotine and Tobacco

J. Henningfield, E. Cone, R. Fant, 2012 .

Detection of marijuana use by oral fluid and urine analysis following single-dose administration of smoked and oral marijuana.

E. Cone, K. Kardos, R. S. Niedbala, 2001, Journal of analytical toxicology.

Cocaine metabolism and urinary excretion after different routes of administration.

E. Cone, J. Oyler, W. D. Darwin, 1998, Therapeutic drug monitoring.

Forensic drug testing for opiates. V. Urine testing for heroin, morphine, and codeine with commercial opiate immunoassays.

E. Cone, E J Cone, S Dickerson, 1993, Journal of analytical toxicology.

Urinary excretion profiles for total morphine, free morphine, and 6-acetylmorphine following smoked and intravenous heroin.

E. Cone, A. Jenkins, M. Smith, 2001, Journal of analytical toxicology.

Detection times and analytical performance of commercial urine opiate immunoassays following heroin administration.

E. Cone, A. Jenkins, M. Smith, 2000, Journal of analytical toxicology.

Validity testing of the TDx Cocaine Metabolite Assay with human specimens obtained after intravenous cocaine administration.

E. Cone, J. Mitchell, S. Menchen, 1988, Forensic science international.

Forensic drug testing for opiates. II. Metabolism and excretion rate of morphine in humans after morphine administration.

E. Cone, J. Mitchell, B. D. Paul, 1991, Journal of analytical toxicology.

Forensic drug testing for opiates, III. Urinary excretion rates of morphine and codeine following codeine administration.

E. Cone, J. Mitchell, B. D. Paul, 1991, Journal of analytical toxicology.

Forensic drug testing for opiates. IV. Analytical sensitivity, specificity, and accuracy of commercial urine opiate immunoassays.

E. Cone, J. Mitchell, S. Dickerson, 1992, Journal of analytical toxicology.

Safety and Efficacy of Bupropion Combined With Bromocriptine for Treatment of Cocaine Dependence

K. Preston, D. Gorelick, E. Cone, 1996 .

Arterial and venous cocaine plasma concentrations in humans: relationship to route of administration, cardiovascular effects and subjective effects.

S. Evans, J. Henningfield, E. Cone, 1996, The Journal of pharmacology and experimental therapeutics.

Urine drug testing of chronic pain patients. V. Prevalence of propoxyphene following its withdrawal from the United States market.

R. Heltsley, E. Cone, Y. Caplan, 2013, Journal of analytical toxicology.

Diazepam and methadone blood levels following concurrent administration of diazepam and methadone.

R. Griffiths, K. Preston, E. Cone, 1986, Drug and alcohol dependence.

A portable pupilometer system for measuring pupillary size and light reflex

J. Henningfield, E. Cone, A. Radzius, 1989 .

Cocaine and metabolite concentrations in plasma during repeated oral administration: development of a human laboratory model of chronic cocaine use.

E. Cone, S. Walsh, R. Jufer, 1998, Journal of analytical toxicology.

Opiate-induced pupillary effects in humans.

J. Henningfield, E. Cone, W. Pickworth, 1989, Methods and findings in experimental and clinical pharmacology.

Identification and quantitation of amphetamines, cocaine, opiates, and phencyclidine in oral fluid by liquid chromatography-tandem mass spectrometry.

E. Cone, D. Fritch, Kristen Blum, 2009, Journal of analytical toxicology.

Pharmacokinetics of Cannabis Brownies: A Controlled Examination of Δ9-Tetrahydrocannabinol and Metabolites in Blood and Oral Fluid of Healthy Adult Males and Females.

G. Bigelow, E. Cone, R. Vandrey, 2020, Journal of analytical toxicology.

Pharmacodynamic effects of vaporized and oral cannabidiol (CBD) and vaporized CBD-dominant cannabis in infrequent cannabis users.

G. Bigelow, E. Cone, R. Vandrey, 2020, Drug and alcohol dependence.

Urinary Pharmacokinetic Profile of Cannabinoids Following Administration of Vaporized and Oral Cannabidiol and Vaporized CBD-Dominant Cannabis.

G. Bigelow, E. Cone, R. Vandrey, 2019, Journal of analytical toxicology.

Urinary Excretion Profile of 11-Nor-9-Carboxy-Δ9-Tetrahydrocannabinol (THCCOOH) Following Smoked and Vaporized Cannabis Administration in Infrequent Cannabis Users.

G. Bigelow, E. Cone, R. Vandrey, 2019, Journal of analytical toxicology.

Acute Pharmacokinetic Profile of Smoked and Vaporized Cannabis in Human Blood and Oral Fluid.

G. Bigelow, E. Cone, R. Vandrey, 2019, Journal of analytical toxicology.

Pharmacokinetic Characterization of 11-nor-9-carboxy-Δ9-tetrahydrocannabinol in Urine Following Acute Oral Cannabis Ingestion in Healthy Adults.

G. Bigelow, E. Cone, R. Vandrey, 2018, Journal of analytical toxicology.

Prescription opioids. III. Disposition of oxycodone in oral fluid and blood following controlled single-dose administration.

R. Heltsley, E. Cone, D. Black, 2015, Journal of analytical toxicology.

Relationship Between Plasma and Oral Fluid Nicotine Concentrations in Humans: A Pilot Study

J. Henningfield, E. Cone, A. Jenkins, 2005, Therapeutic drug monitoring.

Plasma and oral fluid pharmacokinetics and pharmacodynamics after oral codeine administration.

M. Huestis, E. Cone, Insook Kim, 2002, Clinical chemistry.

Cocaine disposition in saliva following intravenous, intranasal, and smoked administration.

E. Cone, J. Oyler, W. Darwin, 1997, Journal of analytical toxicology.

Confirmation of cocaine in human saliva after intravenous use.

E. Cone, K. Kumor, M. Sherer, 1987, Journal of analytical toxicology.

Saliva Testing for Drugs of Abuse

E. Cone, 1993, Annals of the New York Academy of Sciences.

Simultaneous measurement of cocaine, cocaethylene, their metabolites, and "crack" pyrolysis products by gas chromatography-mass spectrometry.

E. Cone, W. Darwin, M. Hillsgrove, 1994, Clinical chemistry.

Intrasubject variation of creatinine and specific gravity measurements in consecutive urine specimens of heroin users.

E. Cone, B. Goldberger, W. Darwin, 1995, Clinical chemistry.

Detection of methadone, methadone metabolites, and other illicit drugs of abuse in hair of methadone-treatment subjects.

E. Cone, Y. Caplan, B. Goldberger, 1998, Journal of analytical toxicology.

Simultaneous quantitation of cocaine, opiates, and their metabolites in human hair by positive ion chemical ionization gas chromatography-mass spectrometry.

E. Cone, D. Rollins, D. Wilkins, 1998, Journal of chromatographic science.

Measurement of heroin and its metabolites by isotope-dilution electron-impact mass spectrometry.

E. Cone, Y. Caplan, A. Allen, 1993, Clinical chemistry.

Disposition of cocaine and its metabolites in human sweat after controlled cocaine administration.

M. Huestis, E. Cone, E. Moolchan, 2005, Clinical chemistry.

Oxymorphone metabolism and urinary excretion in human, rat, guinea pig, rabbit, and dog.

E. Cone, C. Gorodetzky, W. Buchwald, 1983, Drug metabolism and disposition: the biological fate of chemicals.

Sigma compounds derived from phencyclidine: identification of PRE-084, a new, selective sigma ligand.

D. W. Parish, T. Su, E. Cone, 1991, The Journal of pharmacology and experimental therapeutics.

Prescription opioids. II. Metabolism and excretion patterns of hydrocodone in urine following controlled single-dose administration.

R. Heltsley, E. Cone, D. Black, 2013, Journal of analytical toxicology.

Prescription opioids. I. Metabolism and excretion patterns of oxycodone in urine following controlled single dose administration.

R. Heltsley, E. Cone, D. Black, 2013, Journal of analytical toxicology.

Forensic drug testing for opiates. VII. Urinary excretion profile of intranasal (snorted) heroin.

S. B. Needleman, E. Cone, R. Jufer, 1996, Journal of analytical toxicology.

Urine drug testing of chronic pain patients: licit and illicit drug patterns.

E. Cone, Y. Caplan, F. Moser, 2008, Journal of analytical toxicology.

In vivo adulteration: excess fluid ingestion causes false-negative marijuana and cocaine urine test results.

E. Cone, W. Darwin, R. Lange, 1998, Journal of analytical toxicology.

Prevalence and disposition of drugs of abuse and opioid treatment drugs in oral fluid.

E. Cone, L. Tsanaclis, Joe Clarke, 2007, Journal of analytical toxicology.

Methamphetamine and amphetamine pharmacokinetics in oral fluid and plasma after controlled oral methamphetamine administration to human volunteers.

M. Huestis, E. Cone, E. Moolchan, 2003, Clinical chemistry.

Determination of delta 9-tetrahydrocannabinol in human blood and saliva by high-performance liquid chromatography with amperometric detection.

E. Cone, L. Thompson, 1987, Journal of chromatography.

Stability of cocaine in saliva.

E. Cone, S. Menchen, 1988, Clinical chemistry.

Disposition kinetics of nicotine and cotinine enantiomers in rabbits and beagle dogs.

N. Benowitz, P. Jacob, E. Cone, 1988, Journal of pharmaceutical sciences.

Caffeine content of brewed teas.

Michele L. Merves, E. Cone, B. Goldberger, 2008, Journal of analytical toxicology.

Caffeine content of decaffeinated coffee.

M. Gold, E. Cone, B. Goldberger, 2006, Journal of analytical toxicology.

Acute effects of smoking marijuana on hormones, subjective effects and performance in male human subjects

E. Cone, Rolley E. Johnson, J. Roache, 1986, Pharmacology Biochemistry and Behavior.

Urinary excretion half-life of 11-nor-9-carboxy-delta9-tetrahydrocannabinol in humans.

M. Huestis, E. Cone, 1998, Therapeutic drug monitoring.

Nicotine delivery systems

S. Shiffman, K. Fagerström, J. Gitchell, 2005, Expert opinion on drug delivery.

Pharmacodynamic dose effects of oral cannabis ingestion in healthy adults who infrequently use cannabis.

G. Bigelow, E. Cone, R. Vandrey, 2020, Drug and alcohol dependence.

Non-smoker exposure to secondhand cannabis smoke II: Effect of room ventilation on the physiological, subjective, and behavioral/cognitive effects.

G. Bigelow, E. Cone, R. Vandrey, 2015, Drug and alcohol dependence.

Multiple drug ingestion by ecstasy abusers in the United States.

E. Cone, Y. Caplan, F. Moser, 2009, Journal of analytical toxicology.

Cocaine use early in treatment predicts outcome in a behavioral treatment program.

R. Brooner, K. Preston, K. Silverman, 1998, Journal of consulting and clinical psychology.

M. Huestis, E. Cone, E. Moolchan, 2005, Journal of Pharmacology and Experimental Therapeutics.

Confirmatory tests for drugs in the workplace by gas chromatography-mass spectrometry.

E. Cone, B. Goldberger, 1994, Journal of chromatography. A.

Butyrylcholinesterase accelerates cocaine metabolism: in vitro and in vivo effects in nonhuman primates and humans.

N. Greig, S. Goldberg, D. Gorelick, 2000, Drug metabolism and disposition: the biological fate of chemicals.

Plasma butyrylcholinesterase activity and cocaine half-life differ significantly in rhesus and squirrel monkeys.

S. Goldberg, D. Gorelick, E. Cone, 1996, Life sciences.

Urinary excretion profiles of 11-nor-9-carboxy-delta 9-tetrahydrocannabinol in humans after single smoked doses of marijuana.

M. Huestis, E. Cone, J. Mitchell, 1996, Journal of analytical toxicology.

Comparison of self-reported drug use with quantitative and qualitative urinalysis for assessment of drug use in treatment studies.

K. Preston, K. Silverman, E. Cone, 1997, NIDA research monograph.

Risk Management Implications of Abuse Potential Assessment

S. Schnoll, J. Henningfield, E. Cone, 2015 .

Selecting an appropriate isotopic internal standard for gas chromatography/mass spectrometry analysis of drugs of abuse--pentobarbital example.

E. Cone, R. H. Liu, G. Foster, 1995, Journal of forensic sciences.

The metabolism and excretion of buprenorphine in humans.

E. Cone, R. E. Johnson, C. Gorodetzky, 1984, Drug metabolism and disposition: the biological fate of chemicals.

Current and future development of extended-release, abuse-deterrent opioid formulations in the United States

L. Webster, E. Cone, G. Niebler, 2017, Postgraduate medicine.

Legal, workplace, and treatment drug testing with alternate biological matrices on a global scale.

E. Cone, 2001, Forensic science international.

Intravenous and Oral l-α-Acetylmethadol: Pharmacodynamics and Pharmacokinetics in Humans

G. Bigelow, E. Cone, S. Walsh, 1998 .

Concentrations of phenethylamine in dog following single doses and during intravenous self-administration.

E. Cone, M. Risner, G. Neidert, 1978, Research communications in chemical pathology and pharmacology.

Pharmacokinetics and pharmacodynamics of smoked heroin.

J. Henningfield, E. Cone, A. Jenkins, 1994, Journal of analytical toxicology.

Pharmacokinetics and pharmacodynamics of intranasal "snorted" heroin.

E. Cone, B. Goldberger, W. Darwin, 1993, Journal of analytical toxicology.

Morphine pharmacokinetics during anesthesia and surgery in patients with burns.

E. Cone, A. Munster, W. Furman, 1990, Journal of Burn Care and Rehabilitation.

Urinary excretion of hydromorphone and metabolites in humans, rats, dogs, guinea pigs, and rabbits.

E. Cone, C. Gorodetzky, B. A. Phelps, 1977, Journal of pharmaceutical sciences.

Urinary Pharmacokinetic Profile of Cannabidiol (CBD), Δ9-Tetrahydrocannabinol (THC), and their Metabolites Following Oral and Vaporized CBD and Vaporized CBD-Dominant Cannabis Administration.

G. Bigelow, E. Cone, R. Vandrey, 2021, Journal of analytical toxicology.

Oxycodone involvement in drug abuse deaths. II. Evidence for toxic multiple drug-drug interactions.

J. Rohay, E. Cone, Y. Caplan, 2004, Journal of analytical toxicology.

Characterization of the absorption phase of marijuana smoking

M. Huestis, J. Henningfield, E. Cone, 1992, Clinical pharmacology and therapeutics.

Validity testing of the EZ-SCREEN cannabinoid test.

M. Huestis, E. Cone, A. Jenkins, 1993, Journal of analytical toxicology.

Comparative metabolism of hydrocodone in man, rat, guinea pig, rabbit, and dog.

E. Cone, C. Gorodetzky, W. Darwin, 1978, Drug metabolism and disposition: the biological fate of chemicals.

Passive cannabis smoke exposure and oral fluid testing. II. Two studies of extreme cannabis smoke exposure in a motor vehicle.

E. Cone, K. Kardos, R. S. Niedbala, 2005, Journal of analytical toxicology.

Non-smoker exposure to secondhand cannabis smoke. I. Urine screening and confirmation results.

G. Bigelow, E. Cone, R. Vandrey, 2015, Journal of analytical toxicology.

Urine drug testing of chronic pain patients. IV. prevalence of gabapentin and pregabalin.

R. Heltsley, E. Cone, Y. Caplan, 2011, Journal of analytical toxicology.

Clinical pharmacology of buprenorphine: Ceiling effects at high doses

K. Preston, M. Stitzer, G. Bigelow, 1994, Clinical pharmacology and therapeutics.

Time Course of Verapamil Interaction with Morphine Effects on Physiological Parameters in Rats

E. London, E. Cone, F. Ford-Rice, 1989, The Journal of pharmacy and pharmacology.

Spectral studies on cyclic enamino ketones

R. H. Garner, E. Cone, A. Hayes, 1972 .

Ring inversion in 2,4-cyclooctadienone systems

R. H. Garner, E. Cone, A. Hayes, 1972 .

Analytical controls in drug metabolic studies. II. Artifact formation during chloroform extraction of drugs and metabolites with amine substituents.

E. Cone, W. Buchwald, W. Darwin, 1982, Drug metabolism and disposition: the biological fate of chemicals.

Physiologic effects and plasma kinetics of beta-phenylethylamine and its N-methyl homolog in the dog.

E. Cone, H. Shannon, D. Yousefnejad, 1982, The Journal of pharmacology and experimental therapeutics.

Caffeine content of specialty coffees.

Edward J Cone, E. Cone, B. Goldberger, 2003, Journal of analytical toxicology.

Drug testing with alternative matrices II. Mechanisms of cocaine and codeine deposition in hair.

E. Cone, D. Rollins, D. Wilkins, 1999, Journal of analytical toxicology.

The disposition of cocaine and opiate analytes in hair and fingernails of humans following cocaine and codeine administration.

E. Cone, B. Goldberger, J. Ropero‐Miller, 2000, Journal of analytical toxicology.

Opioid disposition in human sweat after controlled oral codeine administration.

M. Huestis, E. Cone, E. Moolchan, 2006, Clinical chemistry.

Cocaine contamination of United States paper currency.

E. Cone, J. Oyler, W. Darwin, 1996, Journal of analytical toxicology.

Determination of δ9-tetrahydrocannabinol in human blood and saliva by high-performance liquid chromatography with amperometric detection

E. Cone, L. Thompson, 1987 .

Incorporation of methamphetamine and amphetamine in human hair following controlled oral methamphetamine administration.

M. Huestis, D. Gorelick, E. Cone, 2012, Analytica chimica acta.

Testing human hair for drugs of abuse. I. Individual dose and time profiles of morphine and codeine in plasma, saliva, urine, and beard compared to drug-induced effects on pupils and behavior.

E. Cone, E J Cone, 1990, Journal of analytical toxicology.

Forensic drug testing for opiates: I. Detection of 6-acetylmorphine in urine as an indicator of recent heroin exposure; drug and assay considerations and detection times.

E. Cone, E J Cone, B D Paul, 1991, Journal of analytical toxicology.

Methamphetamine Disposition in Oral Fluid, Plasma, and Urine

M. Huestis, E. Cone, 2007, Annals of the New York Academy of Sciences.

Assay for codeine, morphine and ten potential urinary metabolites by gas chromatography--mass fragmentography.

E. Cone, W. Buchwald, W. Darwin, 1983, Journal of chromatography.

Detection and measurement of opium alkaloids and metabolites in urine of opium eaters by methane chemical ionization mass fragmentography.

E. Cone, C. Gorodetzky, W. Buchwald, 1982, Journal of chromatography.

Identification and quantitation of alkaloids in coca tea.

E. Cone, A. Jenkins, I. Montoya, 1996, Forensic science international.

Immunoassay evidence for fentanyl in hair of surgery patients.

J. Zacny, E. Cone, W. L. Wang, 1993, Forensic science international.

Testing human hair for drugs of abuse. III. Identification of heroin and 6-acetylmorphine as indicators of heroin use.

B A Goldberger, Y H Caplan, E. Cone, 1991, Journal of analytical toxicology.

Morphine-like discriminative stimulus effects of buprenorphine and demethoxybuprenorphine in rats: quantitative antagonism by naloxone.

E. Cone, H. Shannon, C. Gorodetzky, 1984, The Journal of pharmacology and experimental therapeutics.

Interpretation of Oral Fluid Tests for Drugs of Abuse

Marilyn A Huestis, Edward J Cone, M. Huestis, 2007, Annals of the New York Academy of Sciences.

Relationship of Delta 9-tetrahydrocannabinol concentrations in oral fluid and plasma after controlled administration of smoked cannabis.

Marilyn A Huestis, Edward J Cone, M. Huestis, 2004, Journal of analytical toxicology.

New developments in biological measures of drug prevalence.

E. Cone, 1997, NIDA research monograph.

Major and minor metabolites of cocaine in human plasma following controlled subcutaneous cocaine administration.

Marilyn A Huestis, Edward J Cone, M. Huestis, 2006, Journal of analytical toxicology.

Metabolism and Disposition of Prescription Opioids: A Review.

E. Cone, A. Depriest, B. Puet, 2015, Forensic science review.

Urine drug testing of chronic pain patients. II. Prevalence patterns of prescription opiates and metabolites.

R. Heltsley, E. Cone, Y. Caplan, 2010, Journal of analytical toxicology.

Cocaine and metabolites urinary excretion after controlled smoked administration.

M. Huestis, E. Cone, A. Jenkins, 2007, Journal of analytical toxicology.

Comparison of heroin and cocaine concentrations in saliva with concentrations in blood and plasma.

E. Cone, A. Jenkins, E J Cone, 1995, Journal of analytical toxicology.

Subjective and physiologie effects of intravenous buprenorphine in humans

E. Cone, Rolley E. Johnson, W. Pickworth, 1993, Clinical pharmacology and therapeutics.

Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana.

M. Huestis, J. Henningfield, E. Cone, 1992, Journal of analytical toxicology.

Pharmacokinetic Profile of Δ9-tetrahydrocannabinol, Cannabidiol and Metabolites in Blood following Vaporization and Oral Ingestion of Cannabidiol Products.

G. Bigelow, E. Cone, R. Vandrey, 2022, Journal of analytical toxicology.

Cocaine inhibition of ligand binding at dopamine, norepinephrine and serotonin transporters: a structure-activity study.

M. Kuhar, E. Cone, M. C. Ritz, 1990, Life sciences.

Acute Effects of Smoked and Vaporized Cannabis in Healthy Adults Who Infrequently Use Cannabis

G. Bigelow, E. Cone, R. Vandrey, 2018, JAMA network open.

Buprenorphine treatment of pregnant opioid--dependent women: maternal and neonatal outcomes.

B. Lester, H. Jones, N. Haug, 2001, Drug and alcohol dependence.

Differentiating new marijuana use from residual drug excretion in occasional marijuana users.

M. Huestis, E. Cone, E J Cone, 1998, Journal of analytical toxicology.

Cocaine disposition in meconium from newborns of cocaine-abusing mothers and urine of adult drug users.

K. Preston, E. Cone, P. Suess, 1996, Journal of analytical toxicology.

Pharmacokinetic Profile of Oral Cannabis in Humans: Blood and Oral Fluid Disposition and Relation to Pharmacodynamic Outcomes.

G. Bigelow, E. Cone, R. Vandrey, 2017, Journal of analytical toxicology.

Contact highs and urinary cannabinoid excretion after passive exposure to marijuana smoke

E. Cone, Rolley E. Johnson, E J Cone, 1986, Clinical pharmacology and therapeutics.

Passive cannabis smoke exposure and oral fluid testing.

Edward J Cone, E. Cone, S. Salamone, 2004, Journal of analytical toxicology.

Lowering the federally mandated cannabinoid immunoassay cutoff increases true-positive results.

M. Huestis, E. Cone, J. Mitchell, 1994, Clinical chemistry.

Loweringthe FederallyMandatedCannabinoidImmunoassay CutoffIncreases True-PositiveResults

M. Huestis, E. Cone, John M. Mitchell, 1994 .

Structure-activity relationship studies of phencyclidine derivatives in rats.

R. Mcquinn, E. Cone, H. Shannon, 1984, The Journal of pharmacology and experimental therapeutics.

Plasma concentrations of heroin and morphine-related metabolites after intranasal and intramuscular administration.

E. Cone, G. Skopp, R. Aderjan, 1997, Journal of analytical toxicology.

Core outcome measures for opioid abuse liability laboratory assessment studies in humans: IMMPACT recommendations

Jennifer A. Haythornthwaite, Richard W. Foltin, George E. Bigelow, 2012, PAIN®.

Intravenous buprenorphine reduces pupil size and the light reflex in humans.

E. Cone, W. Pickworth, P. Welch, 1991, Life sciences.

Caffeine content of energy drinks, carbonated sodas, and other beverages.

E. Cone, B. Goldberger, R. R. McCusker, 2006, Journal of analytical toxicology.

Intravenous butyrylcholinesterase administration and plasma and brain levels of cocaine and metabolites in rats.

N. Greig, H. Holloway, D. Gorelick, 2005, European journal of pharmacology.

Prevalence of heroin markers in urine for pain management patients.

R. Heltsley, E. Cone, Y. Caplan, 2014, Forensic science international.

Phencyclidine binding to striatal cocaine receptors

M. Kuhar, E. Cone, J. Boja, 1990, Neuropharmacology.

Oral fluid drug testing of chronic pain patients. II. Comparison of paired oral fluid and urine specimens.

R. Heltsley, E. Cone, Y. Caplan, 2012, Journal of analytical toxicology.

Evidence of morphine metabolism to hydromorphone in pain patients chronically treated with morphine.

E. Cone, Y. Caplan, H. Heit, 2006, Journal of analytical toxicology.

Evidence that morphine is metabolized to hydromorphone but not to oxymorphone.

E. Cone, Y. Caplan, F. Moser, 2008, Journal of analytical toxicology.

Identification of hydrocodone in human urine following controlled codeine administration.

M. Huestis, E. Cone, J. Oyler, 2000, Journal of analytical toxicology.

Duration of detectable methamphetamine and amphetamine excretion in urine after controlled oral administration of methamphetamine to humans.

M. Huestis, E. Cone, E. Moolchan, 2002, Clinical chemistry.

Sweat testing for cocaine, codeine and metabolites by gas chromatography-mass spectrometry.

M. Huestis, E. Cone, E J Cone, 1999, Journal of chromatography. B, Biomedical sciences and applications.

Pharmacokinetics and pharmacodynamics of cocaine.

E. Cone, E J Cone, E. J. Cone, 1995, Journal of analytical toxicology.

Excretion of methamphetamine and amphetamine in human sweat following controlled oral methamphetamine administration.

M. Huestis, E. Cone, E. Moolchan, 2008, Clinical chemistry.

Urinary Pharmacokinetics of Methamphetamine and Its Metabolite, Amphetamine Following Controlled Oral Administration to Humans

M. Huestis, E. Cone, Insook Kim, 2004, Therapeutic drug monitoring.

Prolonged occurrence of cocaine in human saliva and urine after chronic use.

E. Cone, W. Weddington, 1989, Journal of analytical toxicology.

Prescription Opioids. IV: Disposition of Hydrocodone in Oral Fluid and Blood Following Single-Dose Administration.

R. Heltsley, E. Cone, D. Black, 2015, Journal of analytical toxicology.

Oral fluid drug testing of chronic pain patients. I. Positive prevalence rates of licit and illicit drugs.

R. Heltsley, E. Cone, Y. Caplan, 2011, Journal of analytical toxicology.

Prescription Opioids. VI. Metabolism and Excretion of Hydromorphone in Urine Following Controlled Single-Dose Administration.

R. Heltsley, E. Cone, D. Black, 2016, Journal of analytical toxicology.

Urine testing for norcodeine, norhydrocodone, and noroxycodone facilitates interpretation and reduces false negatives.

R. Heltsley, E. Cone, Y. Caplan, 2010, Forensic science international.

A comparison between the Intercept Oral Fluid Collection Device(R) and urinalysis among Baltimore City probationers

George S. Yacoubian, E. Cone, 2006 .

Oral fluid testing: new technology enables drug testing without embarrassment.

E. Cone, 2006, Journal of the California Dental Association.

Forensic drug testing for opiates. VI. Urine testing for hydromorphone, hydrocodone, oxymorphone, and oxycodone with commercial opiate immunoassays and gas chromatography-mass spectrometry.

E. Cone, B. Levine, M. Smith, 1995, Journal of analytical toxicology.

Toxicologic Aspects of Heroin Substitution Treatment

Edward J Cone, K. Preston, E. Cone, 2002, Therapeutic drug monitoring.

Comparative metabolism of codeine in man, rat, dog, guinea‐pig and rabbit: identification of four new metabolites

E. Cone, C. Gorodetzky, W. Darwin, 1979, The Journal of pharmacy and pharmacology.

Monitoring opiate use in substance abuse treatment patients with sweat and urine drug testing.

K. Preston, M. Huestis, E. Cone, 2000, Journal of analytical toxicology.

General procedure for the isolation and identification of 6-α- and 6-β-hydroxy metabolites of narcotic agonists and antagonists with a hydromorphone structure

E. Cone, 1976 .

Correlation between pharmacological effects and plasma cocaine concentrations after smoked administration.

J. Henningfield, E. Cone, A. Jenkins, 2002, Journal of analytical toxicology.

Premier 'smokeless cigarettes' can be used to deliver crack.

J. Henningfield, E. Cone, 1989, JAMA.

The effects of chronic buprenorphine treatment on cocaine and food self-administration by rhesus monkeys.

J. Mendelson, N. Mello, S. Lukas, 1992, The Journal of pharmacology and experimental therapeutics.

Supersensitivity to naloxone following acute morphine pretreatment in humans: behavioral, hormonal and physiological effects.

K. Preston, J. Henningfield, S. Higgins, 1992, Drug and alcohol dependence.

Separation and identification of phencyclidine precursors, metabolites and analogs by gas and thin-layer chromatography and chemical ionization mass spectrometry.

E. Cone, W. Buchwald, D. Yousefnejad, 1979, Journal of chromatography.

Simultaneous determination of phencyclidine and monohydroxylated metabolites in urine of man by gas chromatography-mass fragmentography with methane chemical ionization.

E. Cone, W. Buchwald, D. Yousefnejad, 1981, Journal of chromatography.

Changes in mood, craving, and sleep during short-term abstinence reported by male cocaine addicts. A controlled, residential study.

R. Herning, E. Cone, C. Haertzen, 1990, Archives of general psychiatry.

Subjective response during continuous infusion of cocaine

J. Jaffe, E. Cone, K. Kumor, 1989, Pharmacology Biochemistry and Behavior.

Blood cannabinoids. II. Models for the prediction of time of marijuana exposure from plasma concentrations of delta 9-tetrahydrocannabinol (THC) and 11-nor-9-carboxy-delta 9-tetrahydrocannabinol (THCCOOH)

J E Henningfield, M. Huestis, J. Henningfield, 1992, Journal of analytical toxicology.

Acute and residual effects of marijuana: Profiles of plasma THC levels, physiological, subjective, and performance measures

S. Heishman, M. Huestis, J. Henningfield, 1990, Pharmacology Biochemistry and Behavior.

Disposition of heroin and its metabolites in heroin-related deaths.

E. Cone, Y. Caplan, J. Smialek, 1994, Journal of analytical toxicology.

Monitoring cocaine use in substance-abuse-treatment patients by sweat and urine testing.

K. Preston, M. Huestis, E. Cone, 1999, Journal of analytical toxicology.

Intravenous buprenorphine and norbuprenorphine pharmacokinetics in humans.

K. Preston, M. Huestis, E. Cone, 2013, Drug and alcohol dependence.

Rapid liquid-liquid extraction of cocaine from urine for gas chromatographic-mass spectrometric analysis.

K. Preston, E. Cone, B. Goldberger, 1997, Journal of chromatography. B, Biomedical sciences and applications.

Validity testing of commercial urine cocaine metabolite assays: II. Sensitivity, specificity, accuracy, and confirmation by gas chromatography/mass spectrometry.

E. Cone, J. Mitchell, 1989, Journal of forensic sciences.

Lack of validity of the KDI Quik Test Drug Screen for detection of benzoylecgonine in urine.

E. Cone, S. Menchen, 1987, Journal of analytical toxicology.

Validity testing of commercial urine cocaine metabolite assays: IV. Evaluation of the EMIT d.a.u. cocaine metabolite assay in a quantitative mode for detection of cocaine metabolite.

E. Cone, D. Yousefnejad, S. Dickerson, 1990, Journal of forensic sciences.

Determining zolpidem compliance: urinary metabolite detection and prevalence in chronic pain patients.

R. Heltsley, E. Cone, Y. Caplan, 2014, Journal of analytical toxicology.

Re: Pergolizzi et al., 2010: The Role of Urine Drug Testing for Patients on Opioid Therapy

E. Cone, Yale H. Caplan, 2011, Pain practice : the official journal of World Institute of Pain.

Validity testing of the accuPINCH THC test.

M. Huestis, E. Cone, A. Jenkins, 1995, Journal of analytical toxicology.

Incorporation of codeine and metabolites into hair. Role of pigmentation.

S. Gygi, E. Cone, D. Rollins, 1996, Drug metabolism and disposition: the biological fate of chemicals.

Urinary excretion of ecgonine and five other cocaine metabolites following controlled oral, intravenous, intranasal, and smoked administration of cocaine.

M. Huestis, E. Cone, B. D. Paul, 2010, Journal of analytical toxicology.

Sustained cocaine abstinence in methadone maintenance patients through voucher-based reinforcement therapy.

S T Higgins, R. Brooner, K. Preston, 1996, Archives of general psychiatry.

Use of buprenorphine in the treatment of opiate addiction. I. Physiologic and behavioral effects during a rapid dose induction

J. Henningfield, E. Cone, P. Fudala, 1989, Clinical pharmacology and therapeutics.

Effect of repeated cocaine administration on detection times in oral fluid and urine.

E. Cone, S. Walsh, Angela Sampson-Cone, 2006, Journal of analytical toxicology.

Effects of delivery rate and non-contingent infusion of cocaine on cocaine self-administration in rhesus monkeys

L. Panlilio, S. Goldberg, E. Cone, 1998, Psychopharmacology.

Rapid absorption of nicotine from new nicotine gum formulations

S. Shiffman, J. Gitchell, J. Henningfield, 2009, Pharmacology Biochemistry and Behavior.

Risk of death associated with kratom use compared to opioids.

J. Henningfield, E. Cone, O. Grundmann, 2019, Preventive medicine.

The urinary excretion profile of naltrexone and metabolites in man.

E. Cone, C. Gorodetzky, S. Yeh, 1974, Drug metabolism and disposition: the biological fate of chemicals.

Elevated drug saliva levels suggest a "depot-like" effect in subjects treated with sublingual buprenorphine.

E. Cone, P. Fudala, S. Dickerson, 1990, NIDA research monograph.

Sweat testing for heroin, cocaine, and metabolites.

E. Cone, A. Jenkins, E J Cone, 1994, Journal of analytical toxicology.

Cocaine and metabolite excretion in saliva under stimulated and nonstimulated conditions.

D. Gorelick, E. Cone, E J Cone, 1993, Journal of analytical toxicology.

A comparison of the arterial kinetics of smoked and intravenous cocaine

S. Evans, J. Henningfield, E. Cone, 1993 .

Bioavailability and Pharmacokinetics of Oral Cocaine in Humans.

E. Cone, Marion A. Coe, S. Walsh, 2018, Journal of analytical toxicology.

Effects of High-Dose Intravenous Buprenorphine in Experienced Opioid Abusers

K. Preston, M. Huestis, E. Cone, 2004, Journal of clinical psychopharmacology.

Oxycodone involvement in drug abuse deaths. II. Evidence for toxic multiple drug-drug interactions.

J. Rohay, E. Cone, Y. Caplan, 2004, Journal of analytical toxicology.

The ALERRT® instrument: a quantitative measure of the effort required to compromise prescription opioid abuse-deterrent tablets

E. Cone, K. Lindhardt, A. Buchhalter, 2017, The American journal of drug and alcohol abuse.

Recent discoveries in pharmacokinetics of drugs of abuse.

E. Cone, 1998, Toxicology letters.

Validity testing of commercial urine cocaine metabolite assays: I. Assay detection times, individual excretion patterns, and kinetics after cocaine administration to humans.

E. Cone, J. Mitchell, B. D. Paul, 1989, Journal of Forensic Sciences.

Human metabolism of naltrexone

E. Cone, C. Gorodetzky, S. Yeh, 1973 .

The identification and measurement of two new metabolites of naltrexone in human urine.

E. Cone, F. Carroll, C. Gorodetzky, 1978, Research communications in chemical pathology and pharmacology.

Biosynthesis, isolation, and identification of 6-beta-hydroxynaltrexone, a major human metabolite of naltrexone.

E. Cone, C. Gorodetzky, S. Yeh, 1975, Journal of pharmaceutical sciences.

Human metabolite of naltrexone (n-cyclopropylmethylnoroxymorphone) with a novel C-6 isomorphine configuration

E. Cone, 1973 .

Validity testing of commercial urine cocaine metabolite assays: III. Evaluation of an enzyme-linked immunosorbent assay (ELISA) for detection of cocaine and cocaine metabolite.

E. Cone, 1989, Journal of forensic sciences.

Interdisciplinary studies on phencyclidine at the Addiction Research Center, Lexington, Kentucky [proceedings].

R. Mcquinn, T. Su, E. Cone, 1980, Psychopharmacology bulletin.

Relative potencies of phencyclidine and analogs in the opiate receptor binding assay: Correlation with relative potencies determined in vivo in mouse and rat

T. Su, E. Cone, D. B. Vaupel, 1980 .

Simultaneous assay of buprenorphine and norbuprenorphine by negative chemical ionization tandem mass spectrometry.

E. Cone, B. Levine, J. Magluilo, 1996, Journal of analytical toxicology.

Stability of the 6,14-endo-ethanotetrahydrooripavine analgesics: acid-catalyzed rearrangement of buprenorphine.

E. Cone, C. Gorodetzky, W. Buchwald, 1984, Journal of pharmaceutical sciences.

The metabolism of azidomorphine in a human subject.

E. Cone, 1978, Xenobiotica; the fate of foreign compounds in biological systems.

Analytical controls in drug metabolic studies. A commentary.

E. Cone, C. Gorodetzky, 1975, Drug Metabolism And Disposition.

A retrospective study of buprenorphine and norbuprenorphine in human hair after multiple doses.

G. Krueger, E. Cone, D. Rollins, 1999, Journal of analytical toxicology.

Urine testing for cocaine abuse: metabolic and excretion patterns following different routes of administration and methods for detection of false-negative results.

M. Huestis, E. Cone, J. Oyler, 2003, Journal of analytical toxicology.

Clonidine partially blocks the physiologic effects but not the subjective effects produced by smoking marijuana in male human subjects

E. Cone, W. Lange, P. Welch, 1988, Pharmacology, Biochemistry and Behavior.

The brief abstinence test: voucher-based reinforcement of cocaine abstinence.

K. Preston, K. Silverman, E. Robles, 2000, Drug and alcohol dependence.

Effects of nicotine, cocaine and some of their metabolites on schedule-controlled responding by beagle dogs and squirrel monkeys.

S. Goldberg, E. Cone, M. Risner, 1985, The Journal of pharmacology and experimental therapeutics.

Laboratory-based testing to evaluate abuse-deterrent formulations and satisfy the Food and Drug Administration's recommendation for Category 1 Testing.

E. Cone, A. Buchhalter, E. Kinzler, 2017, Journal of opioid management.

Correlation of saliva cocaine levels with plasma levels and with pharmacologic effects after intravenous cocaine administration in human subjects.

E. Cone, K. Kumor, M. Sherer, 1988, Journal of analytical toxicology.

Relating Blood Concentrations of Tetrahydrocannabinol and Metabolites to Pharmacologic Effects and Time of Marijuana Usage

M. Huestis, E. Cone, E J Cone, 1993, Therapeutic drug monitoring.

Cannabinoid Content and Label Accuracy of Hemp-Derived Topical Products Available Online and at National Retail Stores

E. Cone, R. Vandrey, M. Elsohly, 2022, JAMA network open.

Efficacy of urinalysis in monitoring heroin and cocaine abuse patterns: implications in clinical trials for treatment of drug dependence.

E. Cone, S. Dickerson, 1992, NIDA research monograph.

Phencyclidine analogs and precursors: rotarod and lethal dose studies in the mouse.

E. Cone, D. B. Vaupel, D. McCoun, 1984, The Journal of pharmacology and experimental therapeutics.

Pharmacokinetics of Cocaine and Metabolites in Human Oral Fluid and Correlation With Plasma Concentrations After Controlled Administration

M. Huestis, E. Cone, T. Kelly, 2010, Therapeutic drug monitoring.

Nonsmoker Exposure to Secondhand Cannabis Smoke. III. Oral Fluid and Blood Drug Concentrations and Corresponding Subjective Effects.

G. Bigelow, E. Cone, R. Vandrey, 2015, Journal of analytical toxicology.

Oral fluid testing for drugs of abuse: positive prevalence rates by Intercept immunoassay screening and GC-MS-MS confirmation and suggested cutoff concentrations.

William J. Seiter, E. Cone, S. Salamone, 2002, Journal of analytical toxicology.

Is THC-COOH a useful determinant for passive inhalation in oral fluid THC testing?

J. Walsh, E. Cone, Y. Caplan, 2012, Journal of analytical toxicology.

High prevalence of 6-acetylmorphine in morphine-positive oral fluid specimens.

William J. Seiter, E. Cone, S. Salamone, 2003, Forensic science international.

Barbiturate Detection in Oral Fluid, Plasma, and Urine

E. Cone, K. Kardos, A. Buchhalter, 2011, Therapeutic drug monitoring.

Marijuana-laced brownies: behavioral effects, physiologic effects, and urinalysis in humans following ingestion.

E. Cone, J. Mitchell, B. D. Paul, 1988, Journal of analytical toxicology.

Blood cannabinoids. II: Models for the prediction of time of marijuana exposure from plasma concentrations of Δ9-tetrahydrocannabinol (THC) and 11-nor-9-carboxy-Δ9-tetrahydrocannabinol (THCCOOH)

Jack E. Henningfield, M. Huestis, J. Henningfield, 1992 .

Discriminative stimulus properties and schedule effects of fencamfamine in rats

P. Jackson-smith, E. Cone, M. Risner, 1985, Pharmacology Biochemistry and Behavior.

Suspiciousness induced by four-hour intravenous infusions of cocaine. Preliminary findings.

J. Jaffe, E. Cone, K. Kumor, 1988, Archives of general psychiatry.

Passive inhalation of marijuana smoke: urinalysis and room air levels of delta-9-tetrahydrocannabinol.

E. Cone, E J Cone, B D Paul, 1987, Journal of analytical toxicology.

Short communication Buprenorphine treatment of pregnant opioid-dependent women: maternal and neonatal outcomes

B. Lester, H. Jones, N. Haug, 2001 .

Pharmacodynamic and pharmacokinetic actions of ketocyclazocine enantiomers in the dog: absence of sigma- or phencyclidine-like activity.

E. Cone, D. B. Vaupel, 1991, The Journal of pharmacology and experimental therapeutics.

Time course of detection of 6-acetylmorphine in urine after heroin administration.

E. Cone, P. Welch, 1989, NIDA research monograph.

Monohydroxymetabolites of phencyclidine (PCP): activities and urinary excretion by rat, dog and mouse

E. Cone, D. B. Vaupel, D. Yousefnejad, 1982, The Journal of pharmacy and pharmacology.

Phencyclidine metabolism: resolution, structure, and biological activity of the isomers of the hydroxy metabolite, 4-phenyl-4-(1-piperidinyl)cyclohexanol.

E. Cone, D. B. Vaupel, F. Carroll, 1981, Journal of Medicinal Chemistry.

Passive inhalation of cocaine.

E. Cone, D. Yousefnejad, W. Darwin, 1995, Journal of Analytical Toxicology.

Evaluation of electronic nicotine delivery systems: Regulatory precedents from the FDA 2013 draft guidance for abuse-deterrent opioids

J. Gitchell, J. Henningfield, E. Cone, 2015 .

PHENCYCLIDINE METABOLISM: RESOLUTION, STRUCTURE, AND BIOLOGICAL ACTIVITY OF THE ISOMERS OF THE HYDROXYMETABOLITE, 4-PHENYL-4-(1-PIPERIDINYL)CYCLOHEXANOL

E. Cone, D. B. Vaupel, F. Carroll, 1982 .

Evidence for toxic precursors in illicit phencyclidine preparations

E. Cone, D. B. Vaupel, C. Gorodetzky, 1979 .

Do consecutive urine catches differ in marijuana metabolite concentration?

M. Huestis, E. Cone, J. Mitchell, 1993, Journal of analytical toxicology.

Human pharmacokinetics of intravenous, sublingual, and buccal buprenorphine.

E. Cone, Rolley E. Johnson, B. Levine, 1996, Journal of analytical toxicology.

Physiologic effects and plasma kinetics of phenylethanolamine and its N-methyl homolog in the dog.

E. Cone, H. Shannon, D. Yousefnejad, 1981, Journal of Pharmacology and Experimental Therapeutics.

Oral fluid results compared to self reports of recent cocaine and heroin use by methadone maintenance patients.

E. Cone, 2012, Forensic science international.

Unsuspected ethanol ingestion through soft drinks and flavored beverages.

E. Cone, B. Goldberger, L. Kadehjian, 1996, Journal of analytical toxicology.

Attenuation of cocaine-induced locomotor activity by butyrylcholinesterase.

N. Greig, Qian-sheng Yu, S. Goldberg, 1998, Experimental and clinical psychopharmacology.

Fluorescence properties of pseudomorphine and congeners: structure-activity relationships.

E. Cone, W. Darwin, 1980, Journal of pharmaceutical sciences.

Intravenous self-administration of fencamfamine and cocaine by beagle dogs under fixed-ratio and progressive-ratio schedules of reinforcement.

E. Cone, M. Risner, 1986, Drug and alcohol dependence.

Urine drug testing of chronic pain patients. II. Prevalence patterns of prescription opiates and metabolites.

R. Heltsley, E. Cone, Y. Caplan, 2010, Journal of analytical toxicology.

Urine drug testing of chronic pain patients. V. Prevalence of propoxyphene following its withdrawal from the United States market.

R. Heltsley, E. Cone, Y. Caplan, 2013, Journal of analytical toxicology.

A dose run-up and safety evaluation of nalmefene HCl in human volunteers.

S. Heishman, J. Henningfield, E. Cone, 1989, NIDA research monograph.